Montel Williams' Lenitiv Scientific And Cura Cannabis Solutions Announce Deal To Produce Williams' Lenitiv line
Lenitiv's hemp-derived CBD line has launched nationwide, with expansion of Lenitiv's cannabis-derived line planned for early summer
PORTLAND, Ore - May 17, 2018 (Investorideas.com Newswire) Cura, a leading provider of cannabis oil, has reached an agreement to produce a hemp-derived and a cannabis-derived line for Lenitiv. Today, Lenitiv's hemp-derived CBD Capsules are available online and can be shipped widely. The product was developed and formulated by media personality and Multiple Sclerosis (MS) survivor Montel Williams—one of the highest-profile medical cannabis patients in the United States.
Shortly before his diagnosis with MS in 1999, Williams had been on the set of Touched By An Angel filming an episode he guest starred in when his feet "caught fire." Soon thereafter, Williams was diagnosed and learned that the all-consuming burning sensation in his feet was intractable neuropathic pain. After exhausting traditional remedies, Williams' MS specialist, a neurologist, suggested he try medicinal cannabis, an idea he initially resisted, until he discovered that medical cannabis made the pain in his feet bearable. The Lenitiv brand benefits from Williams' nearly two decades as a medical cannabis patient and was designed with his experience in mind.
Cura will produce Lenitiv products, starting with a hemp-derived CBD line, which launches nationwide today. Separately, Cura will produce Lenitiv's cannabis-derived line which will be available with a number of new products this summer in Oregon and California in compliance with relevant state laws.
Lenitiv CBD Capsules are 100% hemp-derived and contain zero THC. Each bottle contains 30 gel capsules with 50mg of CBD each. Available in two options, Alert is designed to take in the morning, while Relax is designed to consume at night:
- Alert: Formulated with terpenes known to: aid anxiety, depression; pain management; act as an anti-inflammatory and soothe stress; promote alertness and memory retention
- Relax: Formulated with terpenes known to enhance mood, promote relaxation and restful sleep, quell anxiety, depression and insomnia; act as an antioxidant and anti-inflammatory.
"I'm excited to announce our agreement with Cura," said David Racz, CEO of Lenitiv Scientific. "When I partnered with Montel to help him make his patient-focused vision a reality, we realized we would need like-minded partnerships that understood and shared the values that underpin it. Cura not only shares that vision but expresses it in their culture."
Cura's mission is to become the leading provider of cannabis oil in every market it enters and to become the first cannabis company with a billion-dollar valuation. Known for producing Select, the best-selling cannabis brand on the West Coast (CA/OR/NV, According to BDS Analytics), Cura looks forward to offering new and diverse products to the market through wholesale and white label agreements.
"When we first began talking to Montel and his team at Lenitiv, we were drawn to their people-focused vision," said Cameron Forni, Cura's President and co-Founder. "We're really excited about this partnership because the values that underpin Lenitiv are synergistic with ours. It's also an opportunity for us to support and participate in Montel's advocacy for common sense cannabis reform, and we're thrilled to welcome Montel and the team at Lenitiv to our family."
Lenitiv CBD Capsules are available online and ship nationally. Visit www.lenitivproducts.com to purchase.
Cura Cannabis Solutions is one of the largest cannabis brands in America, on a mission to be the leading provider of cannabis oil in legal U.S. and international markets. Our goal is to provide patients and customers with the cleanest, most flavorful high quality cannabis oils, with the safest delivery method available. Makers of the Select Oil and Select CBD brands, Cura was established in Portland, Oregon in 2015 and in 2018, we were named #12 on Oregon Business Magazine's list of the Top 100 Companies to Work For in Oregon. We expanded into California and Nevada in 2017, with new states on the horizon in 2018. Learn more at: www.curacan.com
ABOUT LENITIV SCIENTIFIC
Founded in 2016 by Montel Williams, Melanie McLaughlin and David Racz to make sure the needs of medical cannabis patients continue to be met in an increasingly adult-use market, Lenitiv is a premium brand that offers both hemp-derived CBD products nationwide and cannabis-derived products in Oregon, California and Nevada later this summer. Unlike many other "celebrity brands," Williams is actively involved in Lenitiv, including as its chief formulator, taking advantage of his nearly two decades as a patient himself. Learn more at www.lenitivlabs.com
Jordon Rahmil, 503-509-7645
For Montel Williams and Lenitiv:
p (310) 735.9001 | m (310) 713-4351
Marijuana / Hemp Stocks
At Cannabisinvestorideas.com and Investorideas.com
Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory
Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing
Also check out our AI blog Global Cannabis Investing - features Investor Ideas Cannabis news
This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/